Lista de obras - Tung-Hung Su - Dominio Público Uruguay

APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers

artículo científico publicado en 2007

Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy

artículo científico publicado en 2014

Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus

artículo científico publicado en 2014

Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan.

artículo científico publicado en 2017

Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model

scientific article published on 13 June 2016

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

artículo científico publicado en 2021

Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously.

artículo científico publicado en 2013

Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy

artículo científico publicado en 2013

Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection.

artículo científico publicado en 2014

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives

artículo científico publicado en 2017

Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping

artículo científico publicado en 2015

Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.

artículo científico publicado en 2013

Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan

artículo científico publicado en 2015

Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues.

artículo científico publicado en 2015

Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis

artículo científico publicado en 2020

Emerging hepatitis B virus infection in vaccinated populations: a rising concern?

artículo científico publicado en 2012

Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.

artículo científico publicado en 2017

Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study

scientific article published in Scientific Reports

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients.

artículo científico publicado en 2013

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

artículo científico publicado en 2010

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.

artículo científico publicado en 2016

Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters

artículo científico publicado en 2014

Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation.

artículo científico publicado en 2018

Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study.

artículo científico publicado en 2015

Hepatitis C virus reinfection in people living with human immunodeficiency virus in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study

artículo científico publicado en 2022

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load ⬇️

artículo científico publicado el 11 de febrero de 2012

High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments

artículo científico publicado en 2017

Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection

artículo científico publicado en 2015

Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers.

artículo científico publicado en 2014

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

artículo científico publicado en 2013

Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission ⬇️

artículo científico publicado el 21 de julio de 2011

Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice

scientific article published on 04 October 2016

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up

artículo científico publicado en 2016

Improving clinical outcomes of chronic hepatitis B virus infection.

artículo científico

Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.

artículo científico publicado en 2015

Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy.

artículo científico publicado en 2011

Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin.

artículo científico publicado en 2012

Leakage of air bubbles in subcutaneous emphysema.

artículo científico publicado en 2008

Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D.

artículo científico publicado en 2017

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection

artículo científico publicado en 2013

Milder clinical manifestation of scrub typhus in Kinmen, Taiwan ⬇️

artículo científico publicado el 22 de mayo de 2012

Molecular mechanism and treatment of viral hepatitis-related liver fibrosis

artículo científico publicado en 2014

Multiple Giant Mushroom-like Tumors Inside the Stomach

artículo científico publicado en 2016

One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature

artículo científico publicado en 2017

Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial

artículo científico publicado en 2015

Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial

artículo científico publicado en 2014

Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.

artículo científico publicado en 2015

Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial

artículo científico publicado en 2015

Reply

artículo científico publicado en 2016

Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

artículo científico publicado en 2017

Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.

artículo científico publicado en 2013

Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads ⬇️

artículo científico publicado el 6 de diciembre de 2012

Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications.

artículo científico publicado en 2014

Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B.

artículo científico publicado en 2010

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

artículo científico publicado en 2011

Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.

artículo científico publicado en 2011

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C ⬇️

artículo científico publicado el 23 de abril de 2013

Shear-wave elasticity imaging of a liver fibrosis mouse model using high-frequency ultrasound.

artículo científico publicado en 2015

Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition

artículo científico publicado en 2015

Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis.

artículo científico publicado en 2017

Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir.

artículo científico publicado en 2013

Surveillance of Hepatocellular Carcinoma by Magnetic Resonance Imaging With Liver-Specific Contrast

artículo científico publicado en 2017

Synergistic Effect of Hyperglycemia and Helicobacterpylori Infection Status on Colorectal Adenoma Risk.

artículo científico publicado en 2017

The clinical significance of occult hepatitis B transfusion in Taiwan--a look-back study.

artículo científico

The passage of a colonic cast

artículo científico publicado en 2010

Unusual dyspnoea in a patient with liver cirrhosis.

artículo científico publicado en 2009

Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin.

artículo científico publicado en 2014

Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir

artículo científico publicado en 2013

Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation

artículo científico publicado en 2012

Lista de obras de Tung-Hung Su

APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers

Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy

Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus

Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan.

Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously.

Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy

Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection.

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives

Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping

Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.

Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan

Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues.

Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis

Emerging hepatitis B virus infection in vaccinated populations: a rising concern?

Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.

Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients.

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.

Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters

Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation.

Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study.

Hepatitis C virus reinfection in people living with human immunodeficiency virus in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load ⬇️

High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments

Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection

Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers.

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission ⬇️

Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up

Improving clinical outcomes of chronic hepatitis B virus infection.

Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.

Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy.

Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin.

Leakage of air bubbles in subcutaneous emphysema.

Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D.

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection

Milder clinical manifestation of scrub typhus in Kinmen, Taiwan ⬇️

Molecular mechanism and treatment of viral hepatitis-related liver fibrosis

Multiple Giant Mushroom-like Tumors Inside the Stomach

One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature

Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial

Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial

Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.

Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial

Reply

Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.

Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.

Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads ⬇️

Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications.

Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B.

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C ⬇️

Shear-wave elasticity imaging of a liver fibrosis mouse model using high-frequency ultrasound.

Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition

Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis.

Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir.

Surveillance of Hepatocellular Carcinoma by Magnetic Resonance Imaging With Liver-Specific Contrast

Synergistic Effect of Hyperglycemia and Helicobacterpylori Infection Status on Colorectal Adenoma Risk.

The clinical significance of occult hepatitis B transfusion in Taiwan--a look-back study.

The passage of a colonic cast

Unusual dyspnoea in a patient with liver cirrhosis.

Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin.

Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir

Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation